Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol
Top Cited Papers
Open Access
- 31 October 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Urology
- Vol. 14 (12), 743-752
- https://doi.org/10.1038/nrurol.2017.163
Abstract
The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP–RTSG) has developed a new protocol for the diagnosis and treatment of childhood renal tumours, the UMBRELLA SIOP–RTSG 2016 (the UMBRELLA protocol), to continue international collaboration in the treatment of childhood renal tumours. This protocol will support integrated biomarker and imaging research, focussing on assessing the independent prognostic value of genomic changes within the tumour and the volume of the blastemal component that survives preoperative chemotherapy. Treatment guidelines for Wilms tumours in the UMBRELLA protocol include recommendations for localized, metastatic, and bilateral disease, for all age groups, and for relapsed disease. These recommendations have been established by a multidisciplinary panel of leading experts on renal tumours within the SIOP–RTSG. The UMBRELLA protocol should promote international collaboration and research and serve as the SIOP–RTSG best available treatment standard.Keywords
This publication has 55 references indexed in Scilit:
- Treatment of Pulmonary Metastases in Children With Stage IV Nephroblastoma With Risk-Based Use of Pulmonary RadiotherapyJournal of Clinical Oncology, 2012
- The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 studyEuropean Journal of Cancer, 2012
- Update on Relapses in Unilateral Nephroblastoma Registered in 3 Consecutive SIOP/GPOH Studies - A Report from the GPOH-Nephroblastoma Study GroupKlinische Padiatrie, 2011
- Treatment of relapsed Wilms tumors: lessons learnedExpert Review of Anticancer Therapy, 2009
- Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study GroupPediatric Blood & Cancer, 2007
- Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study GroupPediatric Blood & Cancer, 2007
- Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms’ tumour: Results of a randomised trial (UKW3) by the UK Children’s Cancer Study GroupEuropean Journal of Cancer, 2006
- Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trialThe Lancet, 2004
- Doxorubicin for favorable histology, Stage II–III Wilms tumorCancer, 2004
- High-dose chemotherapy with autologous stem cell rescue in children with nephroblastomaBone Marrow Transplantation, 2002